Concepedia

Anne Väisänen

AV

6

Publications

440

Citations

6

H-Index

1994

Active since

Affiliations

University of Oulu(Current)

Oulu University Hospital

Anne Väisänen is an author at University of Oulu specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

1994–2011

6

Publications

6

MATRIX METALLOPROTEINASE-2 (72 kD TYPE IV COLLAGENASE) EXPRESSION OCCURS IN THE EARLY STAGE OF HUMAN MELANOCYTIC TUMOUR PROGRESSION AND MAY HAVE PROGNOSTIC VALUE

Anne Väisänen, Hannu Tuominen, Matti Kallioinen et al. · The Journal of Pathology · 1996 · 143 citations

Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma

Anne Väisänen, Matti Kallioinen, Pentti J. Taskinen et al. · The Journal of Pathology · 1998 · 133 citations

, , +15

Modulation of M<sub>r</sub> 72,000 and M<sub>r</sub> 92,000 type‐IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma

Erkki Hujanen, Anne Väisänen, Aiping Zheng et al. · International Journal of Cancer · 1994 · 57 citations

Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma

Anne Väisänen, Matti Kallioinen, Taina Turpeenniemi‐Hujanen · Human Pathology · 2008 · 50 citations

, , +12

A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53

Anne Väisänen, Paula Kuvaja, Matti Kallioinen et al. · Human Pathology · 2011 · 35 citations

, , +9

Rows per page

1–5 of 6